Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zifan Pei

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Chemical Society Reviews|January 12, 2023
Bioactive inorganic nanomaterials for cancer theranosticsZifan Pei, Huali Lei, Liang Cheng
Handbook of Experimental Pharmacology|October 27, 2017
Posttranslational Modification of Sodium ChannelsZifan Pei, Yanling Pan, Theodore R Cummins
Exploration (Beijing, China)|November 7, 2023
Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapyHuali Lei, Zifan Pei, Chenyu Jiang, et al.
The Journal of Biological Chemistry|March 13, 2020
<i>S</i>-Palmitoylation of the sodium channel Nav1.6 regulates its activity and neuronal excitabilityYanling Pan, Yucheng Xiao, Zifan Pei, et al.
Nature Communications|June 24, 2016
Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generationZifan Pei, Yucheng Xiao, Jingwei Meng, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Polypyrrole-Coated Low-Crystallinity Iron Oxide Grown on Carbon Cloth Enabling Enhanced Electrochemical Supercapacitor PerformanceChunhui Wu, Zifan Pei, Menglin Lv, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 7, 2023
Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor ImmunotherapyHuali Lei, Quguang Li, Zifan Pei, et al.
Science Bulletin|December 12, 2024
An electrically activable nanochip to intensify gas-ionic-immunotherapyGang Wang, Jingrui Li, Shumin Sun, et al.
Advanced Drug Delivery Reviews|October 18, 2025
Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigmsNailin Yang, Yichi Cai, Shumin Sun, et al.
Breast Cancer Research and Treatment|August 5, 2011
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agentsWenjie Jessie Lu, Cong Xu, Zifan Pei, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Chemical Society Reviews|January 12, 2023
Bioactive inorganic nanomaterials for cancer theranosticsZifan Pei, Huali Lei, Liang Cheng
Handbook of Experimental Pharmacology|October 27, 2017
Posttranslational Modification of Sodium ChannelsZifan Pei, Yanling Pan, Theodore R Cummins
Exploration (Beijing, China)|November 7, 2023
Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapyHuali Lei, Zifan Pei, Chenyu Jiang, et al.
The Journal of Biological Chemistry|March 13, 2020
<i>S</i>-Palmitoylation of the sodium channel Nav1.6 regulates its activity and neuronal excitabilityYanling Pan, Yucheng Xiao, Zifan Pei, et al.
Nature Communications|June 24, 2016
Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generationZifan Pei, Yucheng Xiao, Jingwei Meng, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Polypyrrole-Coated Low-Crystallinity Iron Oxide Grown on Carbon Cloth Enabling Enhanced Electrochemical Supercapacitor PerformanceChunhui Wu, Zifan Pei, Menglin Lv, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 7, 2023
Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor ImmunotherapyHuali Lei, Quguang Li, Zifan Pei, et al.
Science Bulletin|December 12, 2024
An electrically activable nanochip to intensify gas-ionic-immunotherapyGang Wang, Jingrui Li, Shumin Sun, et al.
Advanced Drug Delivery Reviews|October 18, 2025
Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigmsNailin Yang, Yichi Cai, Shumin Sun, et al.
Breast Cancer Research and Treatment|August 5, 2011
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agentsWenjie Jessie Lu, Cong Xu, Zifan Pei, et al.
Pageof 4